Clinical Trial: Observational Study With Investigation of Two Second Generation Laryngeal Masks
Study Status: Completed
Recruit Status: Completed
Study Type: Observational
Official Title: Supraglottic Airways LMA Supreme and Ambu AuraGain in Clinical Practice: a Prospective Observational Study
Brief Summary: In a observational study the second-generation laryngeal masks LMA Supreme and Ambu AuraGain are investigated.
Detailed Summary: After approval from the local ethics committee, data were collected in a prospective, non- randomised study over a three-month period. When contra-indications for laryngeal mask use were absent anaesthesiologists used either Supreme (Teleflex Medical GmbH, Germany) or Gain (Ambu GmbH, Germany). Endpoints were the success rate and time to insertion.
Sponsor: Johannes Gutenberg University Mainz
Current Primary Outcome: Success rate [ Time Frame: 70-98 Percent ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
- Time for insertion [ Time Frame: 5-120 seconds ]
- Leakage in ml.min [ Time Frame: 0-300 ml.min ]
Original Secondary Outcome: Same as current
Information By: Johannes Gutenberg University Mainz
Dates:
Date Received: September 30, 2015
Date Started: January 2015
Date Completion:
Last Updated: January 22, 2017
Last Verified: January 2017